JANE STREET GROUP, LLC - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q2 2024$15,660,347
-31.6%
14,900
-37.4%
0.00%
-20.0%
Q1 2024$22,907,262
-68.1%
23,800
-70.9%
0.01%
-73.7%
Q4 2023$71,844,122
+82.3%
81,800
+70.8%
0.02%
+46.2%
Q3 2023$39,419,784
-35.7%
47,900
-43.8%
0.01%
-38.1%
Q2 2023$61,291,462
+19.0%
85,300
+36.0%
0.02%0.0%
Q1 2023$51,518,709
-4.5%
62,700
-16.2%
0.02%
-16.0%
Q4 2022$53,967,452
+22.0%
74,800
+16.5%
0.02%
+31.6%
Q3 2022$44,225,000
+0.3%
64,200
-13.9%
0.02%0.0%
Q2 2022$44,098,00074,6000.02%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q2 2022
NameSharesValueWeighting ↓
Graticule Asia Macro Advisors LLC 24,000$11,787,0000.56%
Timber Hill LLC 9,800$4,813,0000.18%
SIMPLEX TRADING, LLC 1,126$1,997,0000.09%
Allianz Asset Management GmbH 154,600$75,930,0000.07%
JPMORGAN CHASE & CO 31,100$15,274,0000.00%
View complete list of REGENERON PHARMACEUTICALS shareholders